Vascularization and improved in vivo survival of VEGF-secreting cells microencapsulated in HEMA-MMA

Tissue Engineering

Volumn 13, Issue 9, 2007, Pages 2259-2269

  Vallbacka, Jennifer J ^a   Sefton, Michael V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL GROWTH; COPOLYMERS; ENCAPSULATION; HISTOLOGY; MUSCLE;

ENDOTHELIAL GROWTH FACTOR; EXPLANTATION; HYDROXYETHYL METHACRYLATE-METHYL METHACRYLATE; MURINE FIBROBLAST CELLS; TISSUE CONSTRUCTS; VASCULARIZATION;

TISSUE ENGINEERING;

2 HYDROXYETHYL METHACRYLATE; COMPLEMENTARY DNA; COPOLYMER; METHACRYLIC ACID METHYL ESTER; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN CELL; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CAPSULES; CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; MALE; METHYLMETHACRYLATES; MICE; MICE, INBRED C3H; NEOVASCULARIZATION, PHYSIOLOGIC; POLYHYDROXYETHYL METHACRYLATE; TISSUE ENGINEERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 34548636020     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0284     Document Type: Article

References (45)

1. Folkman, J. Angiogenesis: initiation and control. Ann. NY Acad. Sci. 401, 212, 1982.
2. Sarver, J.G., Fournier, R.L., Goldblatt, P.J., Phares, T.L., Mertz, S.E., Baker, A. R., Mellon, R.J., Horner, J.M., and Selman, S.H. Tracer technique to measure in vivo chemical transport rates within an implantable cell transplantation device. Cell Transplant. 4, 201, 1995.
3. Knight, K.R., Uda, Y., Findlay, M.W., Brown, D.L., Cronin, K.J., Jamieson, E., Tai, T., Keramidaris, E., Penington, A.J., Rophael, J., Harrison, L.C., and Morrison, W.A. Vascularized tissue-engineered chambers promote survival and function of transplanted islets and improve glycemic control. FASEB J. 20, 565, 2006.
4. Lysaght, M.J., and Aebischer, P. Encapsulated cells as therapy. Sci. Am. 280, 76, 1999.
5. Babensee, J.E., and Sefton, M.V. Protein delivery by microencapsulated cells. In: Park, K., Ed. Controlled Drug Delivery: Challenges and Strategies. Oxford: Oxford University Press, 1997, Chapter 15.
6. Li, R.H. Materials for immunoisolated cell transplantation. Adv. Drug Deliv. Rev. 33, 87, 1998.
7. Gill, R.G. Antigen presentation pathways for immunity to islet transplants. Relevance to immunoisolation. Ann. NY Acad. Sci. 875, 255, 1999.
8. Gray, D.W. Encapsulated islet cells: the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. Br. Med. Bull. 53, 777, 1997.
9. Loudovaris, T., Mandel, T.E., and Charlton, B. CD4 + T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8 + T cells and B cells. Transplantation 61, 1678, 1996.
10. Jones, K.S., Sefton, M.V., and Gorczynski, R.M. In vivo Recognition by the host Adaptive immune system of microencapsulated xenogeneic cells. Transplantation 78, 1454, 2004.
11. Hunkeler, D. Bioartificial organs transplanted from research to reality. Nat. Biotechnol. 17, 335, 1999.
12. van Schilfgaarde, R., and de Vos, P. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J. Mol. Med. 77, 199, 1999.
13. Brauker, J.H., Carr-Brendel, V.E., Martinson, L.A., Crudele, J., Johnston, W.D., and Johnson, R.C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 29, 1517, 1995.
14. de, V.P., Faas, M.M., Strand, B., and Calafiore, R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 27, 5603, 2006.
15. Lahooti, S., and Sefton, M.V. Methods for microencapsulation with HEMA-MMA. In: Morgan, J.R., and Yarmush, M.I., eds. Methods in Molecular Medicine: Tissue Engineering Methods and Protocols. Totowa, NJ: Humana Press, 1998, pp. 331-348.
16. Uludag, H., Horvath, V., Black, J.P., and Sefton, M.V. Viability and protein secretion from human hepatoma HepG2. Cells encapsulated in 400-μm polyacrylate microcapsules by submerged nozzle-liquid jet extrusion. Biotechnol. Bioeng. 44, 1199, 1994.
17. Babensee, J.E., and Sefton, M.V. Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response. Tissue Eng 6, 165, 2000.
18. Lahooti, S., and Sefton, M.V. Agarose enhances the viability of intraperitoneally implanted microencapsulated L929 fibroblasts. Cell Transplant. 9, 785, 2000.
19. Fleming, A.J., and Sefton, M.V. Viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated PC12 cells after omental pouch implantation within agarose gels. Tissue Eng. 9, 1023, 2003.
20. Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249, 2000.
21. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27, 1995.
22. Gale, N.W., and Yancopoulos, G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055, 1999.
23. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T.N., Yancopoulos, G.D., and McDonald, D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511, 1999.
24. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature 407, 242, 2000.
25. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19, 1029, 2001.
26. Lu, Y., Shansky, J., Del Tatto, M., Ferland, P., Wang, X., and Vandenburgh, H. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104, 594, 2001.
27. Springer, M.L., Chen, A.S., Kraft, P.E., Bednarski, M., and Blau, H.M. VEGF Gene delivery to muscle: potential role for vasculogenesis in adults. Mol. Cell 2, 549, 1998.
28. Springer, M.L., Ozawa, C.R., Banfi, A., Kraft, P.E., Ip, T.K., Brazelton, T.R., and Blau, H.M. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Mol. Ther. 7, 441, 2003.
29. Suzuki, K., Murtuza, B., Smolenski, R.T., Sammut, I.A., Suzuki, N., Kaneda, Y., and Yacoub, M.H. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104, 1207, 2001.
30. Yau, T.M., Fung, K., Weisel, R.D., Fujii, T., Mickle, D.A., and Li, R.K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104, I218, 2001.
31. Okada, N., Kaneda, Y., Miyamoto, H., Yamamoto, Y., Mizuguchi, H., Tsutsumi, Y., Nakagawa, S., and Mayumi, T. Selective enhancement by tumor necrosis factor-alpha of vascular permeability of new blood vessels induced with agarose Hydrogel-entrapped meth-A fibrosarcoma cells. Jpn. J. Cancer Res. 87, 831, 1996.
32. Rinsch, C., Quinodoz, P., Pittet, B., Alizadeh, N., Baetens, D., Montandon, D., Aebischer, P., and Pepper, M.S. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther. 8, 523, 2001.
33. Schuch, G., Machluf, M., Bartsch, G., Jr., Nomi, M., Richard, H., Atala, A., and Soker, S. In vivo administration of vascular endothelial growth factor VEGF. and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 100, 4622, 2002.
34. Springer, M.L., Hortelano, G., Bouley, D.M., Wong, J., Kraft, P.E., and Blau, H.M. Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor. J. Gene Med. 2, 279, 2000.
35. Loudovaris, T., Jacobs, S., Young, S., Maryanov, D., Brauker, J., and Johnson, R.C. Correction of diabetic Nod mice with insulinomas implanted within Baxter immunoisolation devices. J. Mol. Med. 77, 219, 1999.
36. Sigrist, S., Mechine-Neuville, A., Mandes, K., Calenda, V., Legeay, G., Bellocq, J.P., Pinget, M., and Kessler, L. Induction of angiogenesis in omentum with vascular endothelial growth factor: influence on the viability of encapsulated rat pancreatic islets during transplantation. J. Vasc. Res. 40, 359, 2003.
37. Trivedi, N., Steil, G.M., Colton, C.K., Bonner-Weir, S., and Weir, G.C. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. 9, 115, 2000.
38. Sefton, M.V., Kharlip, L., Horvath, V., and Roberts, T. Controlled release using microencapsulated mammalian cells. J. Control Release 19, 289, 1991.
39. Uludag, H., and Sefton, M.V. Colorimetric assay for cellular activity in microcapsules. Biomaterials 11, 708, 1990.
40. Teichert-Kuliszewska, K., Maisonpierre, P.C., Jones, N., Campbell, A.I., Master, Z., Bendeck, M.P., Alitalo, K., Dumont, D.J., Yancopoulos, G.D., and Stewart, D.J. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 49, 659, 2000.
41. Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. Angiogenesis assays: a critical overview. Clin. Chem. 49, 32, 2003.
42. Peters, M.C., Polverini, P.J., and Mooney, D.J. Engineering vascular networks in porous polymer matrices. J. Biomed. Mater. Res. 60, 668, 2002.
43. Smith, M.K., Peters, M.C., Richardson, T.P., Garbern, J.C., and Mooney, D.J. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng 10, 63, 2004.
44. Smith, M.K., Riddle, K.W., and Mooney, D.J. Delivery of hepatotrophic factors fails to enhance longer-term survival of subcutaneously transplanted hepatocytes. Tissue Eng 12, 235, 2006.
45. Ormiston, M.L. The effect of VEGF-induced angiogenesis on the viability of microencapsulated cells in vivo. 2005. M.A.Sc. dissertation, University of Toronto, Toronto, ON.